Comment on: “Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”

Detalles Bibliográficos
Autores principales: Krebs-Brown, Axel, Munafo, Alain, Gaikwad, Sumedh, Urgatz, Bogumila, Castello-Bridoux, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007443/
https://www.ncbi.nlm.nih.gov/pubmed/31802400
http://dx.doi.org/10.1007/s40262-019-00847-0
Descripción
Sumario:

Ejemplares similares